Livzon Pharmaceutical Group 丽珠集团
3 significant filings since 29 May 2026: 2 on guarantee or financial assistance and 1 on dividend. The latest, on 5 Sep 2026: 关于为子公司提供担保的进展公告.
自 29 May 2026 起有 3 份重大公告：guarantee or financial assistance 2 份、dividend 1 份。最新一份（5 Sep 2026）：关于为子公司提供担保的进展公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 14 Jun 2023 | 华金证券 | 周平 | Outperform 增持 | ▲ | Buy 买入 |
| 2 Jan 2019 | 东莞证券 | 卢立亭 | Buy 买入 | ▼ | Outperform 增持 |
| 20 Aug 2018 | 广证恒生证券研究所 | 唐爱金,冯俊曦 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 东海证券 | 杜永宏 | Buy 买入 | 18 Sep 2026 | 3 | — |
| 国信证券 | 陈曦炳,彭思宇,肖婧舒 | Outperform 增持 | 4 Sep 2026 | 4 | — |
| 西南证券 | 杜向阳,雷瑞 | Unrated | 8 Apr 2026 | 1 | — |
| 东吴证券 | 朱国广,刘若彤 | Buy 买入 | 28 Mar 2026 | 1 | — |
| 开源证券 | 余汝意,刘艺 | Buy 买入 | 26 Mar 2026 | 1 | — |
| 太平洋 | 谭紫媚,张懿 | Buy 买入 | 31 Oct 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 11 reports. 每行为该券商近十二个月的最新研报；11 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。